| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Institut für Pharmakologie (A.S., T.S., G.S., T.G.) Freie
Universität Berlin 14195 Berlin, Germany
Medizinische Klinik und Poliklinik III (R.P.)
Universität Leipzig 04103 Leipzig, Germany
Hyperfunctional endocrine thyroid and testicular
disorders can frequently be traced back to gain-of-function mutations
in glycoprotein hormone receptor genes. Deletion mutations in the third
intracellular (i3) loop of the TSH receptor have recently been
identified as a cause of constitutive receptor activity. To examine
whether the underlying mechanism of receptor activation applies to all
glycoprotein hormone receptors, we created deletion mutations in the LH
and FSH receptors. In analogy to the situation with the TSH receptor, a
deletion of nine amino acids resulted in constitutive activity
irrespective of the location of deletions within the i3 loop of the LH
receptor. In contrast, only one (
563566) of four different 4-amino
acid deletion mutants displayed agonist-independent activity.
Systematic examination of the structural requirements for this effect
in the
563566 mutant revealed that only deletions including D564
resulted in constitutive receptor activity. Replacement of D564 by G,
K, and N led to agonist-independent cAMP formation while introduction
of a negatively charged E silenced constitutive receptor activity,
indicating that an anionic amino acid at this position may be required
to maintain an inactive receptor conformation. Insertion of A residues
up- and downstream of D564 did not perturb receptor quiescence, showing
that a certain degree of spatial freedom of the negatively charged
amino acid within the context of the i3 loop is well tolerated. In
contrast to the results obtained with the LH receptor, deletion of the
corresponding D567 from the i3 loop of the FSH receptor did not cause
constitutive receptor activation, highlighting significant differences
in the activation mechanism of gonadotropin receptors.
This article has been cited by other articles:
![]() |
K. Angelova, F. Fanelli, and D. Puett Contributions of Intracellular Loops 2 and 3 of the Lutropin Receptor in Gs Coupling Mol. Endocrinol., January 1, 2008; 22(1): 126 - 138. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Nurwakagari, A. Breit, C. Hess, H. Salman-Livny, D. Ben-Menahem, and T. Gudermann A conformational contribution of the luteinizing hormone-receptor ectodomain to receptor activation J. Mol. Endocrinol., February 1, 2007; 38(2): 259 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Jaschke, S. Neumann, S. Moore, C. J. Thomas, A.-O. Colson, S. Costanzi, G. Kleinau, J.-K. Jiang, R. Paschke, B. M. Raaka, et al. A Low Molecular Weight Agonist Signals by Binding to the Transmembrane Domain of Thyroid-stimulating Hormone Receptor (TSHR) and Luteinizing Hormone/Chorionic Gonadotropin Receptor (LHCGR) J. Biol. Chem., April 14, 2006; 281(15): 9841 - 9844. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Richter-Unruh, E Korsch, O Hiort, P M Holterhus, A P Themmen, and S A Wudy Novel insertion frameshift mutation of the LH receptor gene: problematic clinical distinction of Leydig cell hypoplasia from enzyme defects primarily affecting testosterone biosynthesis Eur. J. Endocrinol., February 1, 2005; 152(2): 255 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Fanelli, M. Verhoef-Post, M. Timmerman, A. Zeilemaker, J. W. M. Martens, and A. P. N. Themmen Insight into Mutation-Induced Activation of the Luteinizing Hormone Receptor: Molecular Simulations Predict the Functional Behavior of Engineered Mutants at M398 Mol. Endocrinol., June 1, 2004; 18(6): 1499 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gaillard, S. Rouquier, A. Chavanieu, P. Mollard, and D. Giorgi Amino-acid changes acquired during evolution by olfactory receptor 912-93 modify the specificity of odorant recognition Hum. Mol. Genet., April 1, 2004; 13(7): 771 - 780. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chakir, Y. Xiang, D. Yang, S.-J. Zhang, H. Cheng, B. K. Kobilka, and R.-P. Xiao The Third Intracellular Loop and the Carboxyl Terminus of {beta}2-Adrenergic Receptor Confer Spontaneous Activity of the Receptor Mol. Pharmacol., November 1, 2003; 64(5): 1048 - 1058. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sangkuhl, A. Schulz, G. Schultz, and T. Schoneberg Structural Requirements for Mutational Lutropin/Choriogonadotropin Receptor Activation J. Biol. Chem., November 27, 2002; 277(49): 47748 - 47755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Haywood, N. Tymchenko, J. Spaliviero, A. Koch, M. Jimenez, J. Gromoll, M. Simoni, V. Nordhoff, D. J. Handelsman, and C. M. Allan An Activated Human Follicle-Stimulating Hormone (FSH) Receptor Stimulates FSH-Like Activity in Gonadotropin-Deficient Transgenic Mice Mol. Endocrinol., November 1, 2002; 16(11): 2582 - 2591. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Angelova, F. Fanelli, and D. Puett A Model for Constitutive Lutropin Receptor Activation Based on Molecular Simulation and Engineered Mutations in Transmembrane Helices 6 and 7 J. Biol. Chem., August 23, 2002; 277(35): 32202 - 32213. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mukherjee, V. V. Gurevich, A. Preninger, H. E. Hamm, M.-F. Bader, A. T. Fazleabas, L. Birnbaumer, and M. Hunzicker-Dunn Aspartic Acid 564 in the Third Cytoplasmic Loop of the Luteinizing Hormone/Choriogonadotropin Receptor Is Crucial for Phosphorylation-independent Interaction with Arrestin2 J. Biol. Chem., May 10, 2002; 277(20): 17916 - 17927. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Ascoli, F. Fanelli, and D. L. Segaloff The Lutropin/Choriogonadotropin Receptor, A 2002 Perspective Endocr. Rev., April 1, 2002; 23(2): 141 - 174. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Nishi, S. Y. Hsu, K. Zell, and A. J. W. Hsueh Characterization of Two Fly LGR (Leucine-Rich Repeat-Containing, G Protein-Coupled Receptor) Proteins Homologous to Vertebrate Glycoprotein Hormone Receptors: Constitutive Activation of Wild-Type Fly LGR1 But Not LGR2 in Transfected Mammalian Cells Endocrinology, November 1, 2000; 141(11): 4081 - 4090. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-Y. Zhou, D. Yang, W.-Z. Zhu, S.-J. Zhang, D.-J. Wang, D. K. Rohrer, E. Devic, B. K. Kobilka, E. G. Lakatta, H. Cheng, et al. Spontaneous Activation of beta 2- but Not beta 1-Adrenoceptors Expressed in Cardiac Myocytes from beta 1beta 2 Double Knockout Mice Mol. Pharmacol., November 1, 2000; 58(5): 887 - 894. [Abstract] [Full Text] |
||||
![]() |
A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text] |
||||
![]() |
Y.-X. Tao, A. N. Abell, X. Liu, K. Nakamura, and D. L. Segaloff Constitutive Activation of G Protein-Coupled Receptors as a Result of Selective Substitution of a Conserved Leucine Residue in Transmembrane Helix III Mol. Endocrinol., August 1, 2000; 14(8): 1272 - 1282. [Abstract] [Full Text] |
||||
![]() |
R. M. Touyz, L. Jiang, and M. Ram Sairam Follicle-Stimulating Hormone Mediated Calcium Signaling by the Alternatively Spliced Growth Factor Type I Receptor Biol Reprod, April 1, 2000; 62(4): 1067 - 1074. [Abstract] [Full Text] |
||||
![]() |
T. Pomorski, T. F. Meyer, and M. Naumann Helicobacter pylori-induced Prostaglandin E2 Synthesis Involves Activation of Cytosolic Phospholipase A2 in Epithelial Cells J. Biol. Chem., January 5, 2001; 276(1): 804 - 810. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Nakabayashi, M. Kudo, B. Kobilka, and A. J. W. Hsueh Activation of the Luteinizing Hormone Receptor Following Substitution of Ser-277 with Selective Hydrophobic Residues in the Ectodomain Hinge Region J. Biol. Chem., September 22, 2000; 275(39): 30264 - 30271. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Schulz, K. Bruns, P. Henklein, G. Krause, M. Schubert, T. Gudermann, V. Wray, G. Schultz, and T. Schoneberg Requirement of Specific Intrahelical Interactions for Stabilizing the Inactive Conformation of Glycoprotein Hormone Receptors J. Biol. Chem., November 22, 2000; 275(48): 37860 - 37869. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |